Genelabs Technologies, Inc.

Research Focus

	Addressing Unmet Medical Needs Drug Discovery Process Progress & Next Steps

Small Molecule Drug Discovery

	HCV Discovery
Resources
	Pipeline Research Posters Research Publications Glossary

/ Research

	Genelabs' research is conducted by a drug discovery organization whose goal is to identify, optimize and develop innovative small molecules in therapeutic areas where significant unmet need exists. Our core competencies include medicinal chemistry, computational modeling, assay development and biological screening. Our individual program objectives are to discover first-in-class new drugs, when novel mechanisms are being explored, or best-in-class new drugs, in cases such as our HCV programs.